Abstract
Diagnostic blood tests can guide the administration of healthcare to save and improve lives. Most clinical biosensing blood tests require a trained technician and specialized equipment to process samples and interpret results, which greatly limits test accessibility. Colorimetric paper-based diagnostics have an equipment-free readout, but raw blood obscures a colorimetric response which has motivated diverse efforts to develop blood sample processing techniques. This work uses inexpensive readily-available materials to engineer user-friendly dilution and filtration methods for blood sample collection and processing to enable a proof-of-concept colorimetric biosensor that is responsive to glutamine in 50 µL blood drop samples in less than 30 min. Paper-based user-friendly blood sample collection and processing combined with CFPS biosensing technology represents important progress towards the development of at-home biosensors that could be broadly applicable to personalized healthcare.
Funder
Simmons Center for Cancer Research at Brigham Young University
Subject
Clinical Biochemistry,General Medicine,Analytical Chemistry,Biotechnology,Instrumentation,Biomedical Engineering,Engineering (miscellaneous)
Reference93 articles.
1. Service readiness of health facilities in Bangladesh, Haiti, Kenya, Malawi, Namibia, Nepal, Rwanda, Senegal, Uganda and the United Republic of Tanzania;Leslie;Bull. World Health Organ.,2017
2. Synthetic biology in the clinic: Engineering vaccines, diagnostics, and therapeutics;Tan;Cell,2021
3. The application of personal glucose meters as universal point-of-care diagnostic tools;Lisi;Biosens. Bioelectron.,2020
4. Detection platforms for point-of-care testing based on colorimetric, luminescent and magnetic assays: A review;Yang;Talanta,2019
5. Point-of-care cancer diagnostic devices: From academic research to clinical translation;Syedmoradi;Talanta,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献